Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: Amgen biosimilar ban, new UPC judges

Sep 21, 2020 South San Francisco / CA / USA - Amgen sign at their headquarters in Silicon Valley; Amgen Inc. is an American multinational biopharmaceutical company

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Amgen appeals over orphan drug biosimilar ban

Amgen has appealed against a German court order issued last Friday, August 4, after having earlier been forced to pull a drug for a rare blood disorder from the German market.

Alexion, a UK-based biologics developer owned by AstraZeneca, asserted orphan drug exclusivity (ODE) rights on its antibody treatment Soliris (eculizumab) against Amgen at the Munich Regional Court earlier this year.

Click here to read the full story.

Latest UPC judges named, more to come

The Unified Patent Court has unveiled the names of 21 newly appointed technically qualified judges.

The UPC published the list of names on its website on Wednesday, August 9. The decision to appoint new TQJs was taken on June 2 by the UPC’s Administrative Committee.

Click here to read the full story.

Interim head of EUIPO Boards of Appeal named

Gordon Humphreys will act as interim president of the EUIPO’s Boards of Appeal from October 1, Managing IP can confirm.

Humphreys, who chairs the First and Third Boards of Appeal, will take on the role once João Negrão, who is the current BoA president, takes over as executive director of the EUIPO.

Click here to read the full story.

Other articles published by Managing IP this week include:

PEP talk: counsel split on whether firms should trumpet partner earnings

Don't be a 'guinea pig' after Medtronic Fed Circuit case: counsel

Weekly take: No harm in senators exploring patent alternatives

AI is changing the way law firms work … here’s how

Five minutes with ... Victoria Randall, IP associate at Finnegan

CJEU more open to EUTM appeals after lengthy lockdown

Syngenta IP head laments ‘missed’ G2/21 opportunity amid EPO quality concerns

Quantum companies: tech complexity creates patent obstacles

Match made in heaven: how firms pick the right merger partners

Elsewhere in IP

Lost in translation

Writer and poet Yilin Wang has settled her copyright case against the British Museum after it admitted it used her translations without permission in an exhibition.

Wilko collapse

UK high street retailer Wilko’s collapse into administration this week has sparked discussion over potential intellectual property implications. Emma Kennaugh-Gallacher, a senior professional support lawyer at IP firm Mewburn Ellis in the UK, said administrators should consider Wilko’s IP assets as early as possible.

Wilko’s brand and range of household products have been protected with a corresponding portfolio of registered trademarks and designs and represent “substantial value,” Kennaugh-Gallacher said.

UKIPO priorities

The UKIPO listed standard essential patents (SEPs) and artificial intelligence among itsanalysis priorities on Tuesday, August 8. The document identifies the office’s main research objectives for the next 12 to 18 months. The UKIPO also vowed to undertake “ground-breaking research and analysis” to support the development of the UK’s IP framework.

Chinese wall

Dentons has split from its Chinese arm, Dacheng Law Offices, the firm confirmed on Tuesday, August 8. Both entities will operate as separate outfits in the future.

Dentons attributed the decision to the Chinese government’s regulatory mandates on local law firms. Both firms joined forces in 2015 to become the largest law firm globally by headcount, with 6,500 lawyers in around 50 offices.

UPC’s SEP debut

Panasonic has targeted Oppo in the first SEP complaint filed at the Unified Patent Court.

The Japanese tech firm has also filed suits in China, Germany, and the UK, it said in a statement on Wednesday, August 9.

Panasonic has also filed actions against Xiaomi.

The Tetris Effect

The editor-in-chief of tech news website Gizmodo has sued Apple and The Tetris Company in a New York federal court for adapting his book into a film without permission.

Dan Ackerman said he sent his 2016 book “The Tetris Effect” to the company behind the video game, which subsequently hit him with a cease-and-desist notice.

That's it for today, see you again next week.

more from across site and ros bottom lb

More from across our site

Cyril Amarchand Mangaldas has hired former Anand & Anand partner Swati Sharma and hopes to compete with specialist IP firms
Rapporteur-Judge András Kupecz ruled that education and training weren’t legitimate reasons for a member of the public to access documents
Searches for comparison prior art will be a little easier, but practitioners will have to put more thought into claim construction and design patent titles
The Helsinki local division rejected AIM Sport’s request for a preliminary injunction in a dispute with rival Supponor
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
The FTC’s plans to scrutinise improperly listed Orange Book patents could make these listings more important in litigation, but firms should be looking at this anyway
Counsel at Debevoise & Plimpton explain how they helped food delivery business Grubhub avoid a preliminary injunction at the Court of Appeals for the Seventh Circuit
European lawyers tell Managing IP how the legal market is reacting to the first few months of the UPC and why cases are set to take off
The ban could be extended or cancelled, depending on whether Judge Pauline Newman cooperates with an investigation, the Judicial Council of the Federal Circuit stated
Sources say some China-based lawyers are prepared to take large pay cuts to join stable practices, but most firms are sceptical about new hires